Cytotherapy

Article	Citations
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Th	1290
Yield of human adipose-derived adult stem cells from liposuction aspirates	537
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature	370
Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: produc	216
Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture	211
Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta	211
Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy	210
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM	199
Mesenchymal stem/progenitor cells developed in cultures from UC blood	181
Exosomes from dental pulp stem cells rescue human dopaminergic neurons from 6-hydroxy-dopamine–induced apoptosis	158
Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells	151
Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6	140
A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a ca	122
Zoledronate facilitates large-scale ex vivo expansion of functional γδ T cells from cancer patients for use in adoptive immunotherapy*	114
Human adipose-derived stem cells isolated from young and elderly women: their differentiation potential and scaffold interaction during in vitro osteoblastic differentiation	110
Manufacturing and characterization of extracellular vesicles from umbilical cord–derived mesenchymal stromal cells for clinical testing	110
Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device	109
Exosomes derived from endothelial progenitor cells attenuate vascular repair and accelerate reendothelialization by enhancing endothelial function	108
Hepatoprotective effect of exosomes from human-induced pluripotent stem cell–derived mesenchymal stromal cells against hepatic ischemia-reperfusion injury in rats	102
Safety evaluation of exosomes derived from human umbilical cord mesenchymal stromal cell	98
Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury	97
Secretomes from bone marrow–derived mesenchymal stromal cells enhance periodontal tissue regeneration	95
Anterior cruciate ligament constructs fabricated from human mesenchymal stem cells in a collagen type I hydrogel	94
Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells	89
Highly enriched cardiomyocytes from human embryonic stem cells	89

Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: evidence from a study in rhesus monkeys	88
Comparison of human mesenchymal stem cells derived from adipose and cord tissue	88
Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency	88
Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow–derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus	84
A large-scale method for the selective depletion of αβ T lymphocytes from PBSC for allogeneic transplantation	82
Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression	80
International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations	78
Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis	78
An alternative method for the isolation of mesenchymal stromal cells derived from lipoaspirate samples	77
Cell sheet technology: a promising strategy in regenerative medicine	77
Manufacturing chimeric antigen receptor T cells: issues and challenges	76
Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta	74
Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells	72
Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: a pilot study	72
Freshly isolated stromal cells from the infrapatellar fat pad are suitable for a one-step surgical procedure to regenerate cartilage tissue	72
Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells	70
Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider	70
Factors secreted from dental pulp stem cells show multifaceted benefits for treating acute lung injury in mice	69
Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice	64
Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategies	64
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial	63
Transplantation of islet-like cell clusters derived from human dental pulp stem cells restores normoglycemia in diabetic mice	63
Comparative study of stemness characteristics of mesenchymal cells from bone marrow of children and adults	63
Age influence on stromal vascular fraction cell yield obtained from human lipoaspirates	61
Low oxygen atmosphere facilitates proliferation and maintains undifferentiated state of umbilical cord mesenchymal stem cells in an hypoxia inducible factor-dependent manner	60
Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA/BCL-2 expression	60
Comparative analysis of the immunomodulatory capacities of human bone marrow– and adipose tissue–derived mesenchymal stromal cells from the same donor	58
Generating neuron-like cells from BM-derived mesenchymal stromal cells in vitro	58
Qualitative and quantitative differences of adipose-derived stromal cells from superficial and deep subcutaneous lipoaspirates: a matter of fat	57
Comparison of human mesenchymal stromal cells from four neonatal tissues: Amniotic membrane, chorionic membrane, placental decidua and umbilical cord	55
Conditioned medium from amniotic membrane-derived cells prevents lung fibrosis and preserves blood gas exchanges in bleomycin-injured mice—specificity of the effects and insights into possible mechani	54
Neural differentiation ability of mesenchymal stromal cells from bone marrow and adipose tissue: a comparative study	54
Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion	54
Preservation of cell-based immunotherapies for clinical trials	54
Selection of CD271+ cells and human AB serum allows a Large expansion of mesenchymal stromal cells from human bone marrow	54
Proliferation, differentiation and characterization of osteoblasts from human BM mesenchymal cells	53
Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease	52
Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood	51
Stem cells from human exfoliated deciduous teeth (SHED) enhance wound healing and the possibility of novel cell therapy	51
Mesenchymal stromal cells derived from umbilical cord blood migrate in response to complement C1q	50
Expansion of HPCs from cord blood in a novel 3D matrix	49
Extracellular vesicles released from mesenchymal stromal cells stimulate bone growth in osteogenesis imperfecta	49
Chimeric antigen receptor–T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goods	49
Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients	49
Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at U.S. academic centers	49
Endothelial progenitor cell therapy for chronic wound tissue regeneration	48
Surface characterization and chondrogenic differentiation of mesenchymal stromal cells derived from synovium	48
A simple and efficient method for generating Nurr1-positive neuronal stem cells from human wisdom teeth (tNSC) and the potential of tNSC for stroke therapy	47
Morphological profiling using machine learning reveals emergent subpopulations of interferon-γ–stimulated mesenchymal stromal cells that predict immunosuppression	46
Soluble factors derived from human amniotic epithelial cells suppress collagen production in human hepatic stellate cells	45

Treatment of human cells derived from MERRF syndrome by peptide-mediated mitochondrial delivery	45
Human umbilical cord mesenchymal stromal cells rescue mice from acetaminophen-induced acute liver failure	44
Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection	44
Mesenchymal stem cells in the treatment of articular cartilage degeneration: New biological insights for an old-timer cell	44
Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels	43
Comparative analysis of mesenchymal stromal cells from murine bone marrow and amniotic fluid	42
Immunosuppressive properties of mesenchymal stromal cell cultures derived from the limbus of human and rabbit corneas	41
Reversal of experimental diabetes in mice by transplantation of neo-islets generated from human amnion-derived mesenchymal stromal cells using immuno-isolatory macrocapsules	40
Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy	40
Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab	38
In vitro extracorporeal shock wave treatment enhances stemness and preserves multipotency of rat and human adipose-derived stem cells	37
The adipose tissue–derived stromal vascular fraction cells from lipedema patients: Are they different?	37
Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions	37
Cryopreservation has no effect on function of natural killer cells differentiated in vitro from umbilical cord blood CD34 + cells	36
Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial	36
Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jelly	36
Efficacy and safety of mesenchymal stromal cell treatment from related donors for patients with refractory aplastic anemia	35
A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy	35
Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway	35
Mesenchymal stromal cells from dermal and adipose tissues induce macrophage polarization to a pro-repair phenotype and improve skin wound healing	34
Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & Gene Therapy	34
Isolation and characterization of mesenchymal stromal cells from human anterior cruciate ligament	34
Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy	34
Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study	33
Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood	33
Fetal mesenchymal stromal cells from cryopreserved human chorionic villi: cytogenetic and molecular analysis of genome stability in long-term cultures	33
Novel cryoprotectant significantly improves the post-thaw recovery and quality of HSC from CB	33
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease	33
Transfer of PR1-specific T-cell clones from donor to recipient by stem cell transplantation and association with GvL activity	33
Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differe	33
Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic c	32
In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials	32
Good manufacturing practice-grade production of unrestricted somatic stem cell from fresh cord blood	32
Current state of U.S. Food and Drug Administration regulation for cellular and gene therapy products: potential cures on the horizon	32
Quality compliance in the shift from cell transplantation to cell therapy in non-pharma environments	32
Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer	31
Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte–colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter pr	31
Direct transplantation of native pericytes from adipose tissue: A new perspective to stimulate healing in critical size bone defects	31
A comparative analysis of the adipogenic potential in human mesenchymal stromal cells from cord blood and other sources	31
Rapamycin enriches for CD4+ CD25+ CD27+ Foxp3+ regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis	31
Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity	30
Small extracellular vesicle loading systems in cancer therapy: Current status and the way forward	30
Mesenchymal stem cell–derived extracellular vesicles: a new impetus of promoting angiogenesis in tissue regeneration	30
Enhanced neuro-therapeutic potential of Wharton's Jelly–derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture	30
Individual and combined effects of mesenchymal stromal cells and recombinant stimulatory cytokines on the in vitro growth of primitive hematopoietic cells from human umbilical cord blood	29
Characterization of hematopoietic stem cell subsets from patients with multiple myeloma after mobilization with plerixafor	28
Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data	28
Scalability and process transfer of mesenchymal stromal cell production from monolayer to microcarrier culture using human platelet lysate	28
Isolation of oligodendrocyte-like cells from human umbilical cord blood	28
Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of Aspergillus fumigatus	28
Adalimumab improves cognitive impairment, exerts neuroprotective effects and attenuates neuroinflammation in an Aβ1-40-injected mouse model of Alzheimer's disease	28
Intrastriatal transplantation of stem cells from human exfoliated deciduous teeth reduces motor defects in Parkinsonian rats	27
Efficient isolation and enrichment of mesenchymal stem cells from bone marrow	26
Stem cell–based biological pacemakers from proof of principle to therapy: a review	26
Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes	26
T-lymphocyte function from peripheral blood stem-cell donors is inhibited by activated granulocytes	26
Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains	26
Isolation and characterization of stem cells from pancreatic islet: pluripotency, differentiation potential and ultrastructural characteristics	26
Isolation and expansion of oligodendrocyte progenitor cells from cryopreserved human umbilical cord blood	26
Umbilical cord tissue–derived mesenchymal stromal cells maintain immunomodulatory and angiogenic potencies after cryopreservation and subsequent thawing	26
Tumor-infiltrating lymphocytes: Streamlining a complex manufacturing process	25
Overcoming the bottleneck of platelet lysate supply in large-scale clinical expansion of adipose-derived stem cells: A comparison of fresh versus three types of platelet lysates from outdated buffy co	25
Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation	25
Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets	24
Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential	24
Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers	24
Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting	24
Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties	24
Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies	24
Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies	24
Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood	24
Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse model	23
A novel method to expand large numbers of CD56+ natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation	23
MSCs can be differentially isolated from maternal, middle and fetal segments of the human umbilical cord	22
Sildenafil improves long-term effect of endothelial progenitor cell-based treatment for monocrotaline-induced rat pulmonary arterial hypertension	22
Transplantation of porcine embryonic stem cells and their derived neuronal progenitors in a spinal cord injury rat model	22
Variation in primary and culture-expanded cells derived from connective tissue progenitors in human bone marrow space, bone trabecular surface and adipose tissue	22
Aggregation of human mesenchymal stem cells enhances survival and efficacy in stroke treatment	22
Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties	21
Optimization of manufacturing conditions for chimeric antigen receptor T cells to favor cells with a central memory phenotype	21

Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of γδ T cells expanded from peripheral blood cells by stimulation with zoledronate	20
Determination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations	20
Autologous cryopreserved leukapheresis cellular material for chimeric antigen receptor–T cell manufacture	20
PARKIN overexpression in human mesenchymal stromal cells from Wharton's jelly suppresses 6-hydroxydopamine–induced apoptosis: Potential therapeutic strategy in Parkinson's disease	20
Mesenchymal stromal cells derived from CD271+ bone marrow mononuclear cells exert potent allosuppressive properties	20
Comparative characterization of mesenchymal stromal cells from multiple abdominal adipose tissues and enrichment of angiogenic ability via CD146 molecule	20
Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress	20
Bone marrow–derived mesenchymal stromal cells ameliorate severe acute pancreatitis in rats via hemeoxygenase-1–mediated anti-oxidant and anti-inflammatory effects	20
Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses	19
Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment	19
A highly standardized and characterized human platelet lysate for efficient and reproducible expansion of human bone marrow mesenchymal stromal cells	19
Extracorporeal shockwave treatment: A novel tool to improve Schwann cell isolation and culture	19
Fetal liver-conditioned medium induces hepatic specification from mouse bone marrow mesenchymal stromal cells: a novel strategy for hepatic transdifferentiation	19
Prospective isolation of stromal progenitor cells from mouse BM	19
Identification of senescent cells in multipotent mesenchymal stromal cell cultures: Current methods and future directions	19
Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metab	19
Standardized xeno- and serum-free culture platform enables large-scale expansion of high-quality mesenchymal stem/stromal cells from perinatal and adult tissue sources	19
Uptake of antigens from modified vaccinia Ankara virus-infected leukocytes enhances the immunostimulatory capacity of dendritic cells	19
Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy	19
Mesenchymal stem cells preconditioned by staphylococcal enterotoxin B enhance survival and bacterial clearance in murine sepsis model	19
Levels of IL-17F and IL-33 correlate with HLA-DR activation in clinical-grade human bone marrow–derived multipotent mesenchymal stromal cell expansion cultures	18
Transplantation of mesenchymal stromal cells on mineralized collagen leads to ectopic matrix synthesis in vivo independently from prior in vitro differentiation	18
Proteomic analysis of human mesenchymal stromal cells derived from adipose tissue undergoing osteoblast differentiation	18
Derivation of lung epithelium from bone marrow cells	18
Functional and immunophenotypic characteristics of isolated CD105+ and fibroblast+ stromal cells from AML: implications for their plasticity along endothelial lineage	18
HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy	18
Enhanced generation of megakaryocytes from umbilical cord blood-derived CD34+ cells expanded in the presence of two nutraceuticals, docosahexanoic acid and arachidonic acid, as supplements to the cyto	18
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies	18
Enrichment isolation of adipose-derived stem/stromal cells from the liquid portion of liposuction aspirates with the use of an adherent column	17
Insulin-like growth factor 2 regulates the proliferation and differentiation of rat adipose-derived stromal cells via IGF-1R and IR	17
Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed	17
Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions	17
DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects: A potential role of adenosine	17
Development and operation of a quality assurance system for deviations from standard operating procedures in a clinical cell therapy laboratory	17
Impact of chronicity of injury on the proportion of mesenchymal stromal cells derived from anterior cruciate ligaments	16
Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases	16
Hematopoietic recovery of acute radiation syndrome by human superoxide dismutase–expressing umbilical cord mesenchymal stromal cells	16
A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies	16
Evaluation of mobilized peripheral blood CD34+ cells from patients with severe coronary artery disease as a source of endothelial progenitor cells	16
Mesenchymal stromal cells from donors varying widely in age are of equal cellular fitness after in vitro expansion under hypoxic conditions	16
Three specific antigens to isolate endothelial progenitor cells from human liposuction material	16
Impaired circulating myeloid DCs from myeloma patients	16
Recent progress on developing exogenous monocyte/macrophage-based therapies for inflammatory and degenerative diseases	16
Adoptive immunotherapy with the use of regulatory T cells and virus-specific T cells derived from cord blood	16
In vitro characterization of two lineage-negative CD34+ cell-enriched hematopoietic cell populations from human UC blood	16
Mesenchymal stromal cells from unconventional model organisms	16
Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy	16
Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood	15
Sub-confluent culture of human mesenchymal stromal cells on biodegradable polycaprolactone microcarriers enhances bone healing of rat calvarial defect	15
Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanoma	15
Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group	15
Selective elimination of alloreactivity from immunotherapeutic T cells by photodynamic cell purging and memory T-cell sorting	15
Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy	15
A comparison of ex vivo expanded DCs derived from cord blood and mobilized adult peripheral blood plastic-adherent mononuclear cells: decreased alloreactivity of cord blood DCs	15
Isolation and trans-differentiation of mesenchymal stromal cells into smooth muscle cells: Utility and applicability for cell-sheet engineering	15
A phase II randomized clinical trial for the treatment of recalcitrant chronic leg ulcers using centrifuged adipose tissue containing progenitor cells	15
Herpes simplex virus type 1 (HSV-1) specific T-cell generation from HLA-A1- and HLA-A2-positive donors for adoptive immunotherapy	14
Prediction of CD34 + cell yield in hematopoietic cell products from children by peripheral blood CD34 + cell counts	14
CD133 immunomagnetic separation: effectiveness of the method for CD133+ isolation from umbilical cord blood	14
CD19 chimeric antigen receptor (CAR) engineered epstein-barr virus (EBV) specific T cells – an off-the-shelf, allogeneic CAR T-cell immunotherapy platform	14
Functional and ultrastructural analysis of endothelial-like cells derived from bone marrow stromal cells	14
Telomerase activity and expression in adult human mesenchymal stem cells derived from amyotrophic lateral sclerosis individuals	14
Cryopreservation timing is a critical process parameter in a thymic regulatory T-cell therapy manufacturing protocol	14
Cycloxygenase-2 inhibition potentiates trans-differentiation of Wharton's jelly–mesenchymal stromal cells into endothelial cells: Transplantation enhances neovascularization-mediated wound repair	14
Production of erythrocytes from directly isolated or Delta1 Notch ligand expanded CD34+ hematopoietic progenitor cells: process characterization, monitoring and implications for manufacture	14
Combined use of N-acetylcysteine and Liberase improves the viability and metabolic function of human hepatocytes isolated from human liver	14
Ex vivo expansion of neutrophil precursor cells from fresh and cryopreserved cord blood cells	14
Optimizing the transport and storage conditions of current Good Manufacturing Practice –grade human umbilical cord mesenchymal stromal cells for transplantation (HUC-HEART Trial)	14
Expanded umbilical cord blood T cells used as donor lymphocyte infusions after umbilical cord blood transplantation	14
Derivation of male germ cells from induced pluripotent stem cells by inducers: A review	13
Three-dimensional culture and characterization of mononuclear cells from human bone marrow	13
Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells	13
Current state of Health Canada regulation for cellular and gene therapy products: potential cures on the horizon	13
Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific Thelper cell response	13
Allogeneic chondrogenically differentiated human mesenchymal stromal cells do not induce immunogenic responses from T lymphocytes in vitro	13
Differential properties of human stromal cells from bone marrow, adipose, liver and cardiac tissues	13
The efficacy of anti-CD19 chimeric antigen receptor T cells for B-cell malignancies	13
Response to Nature commentary “Clear up this stem-cell mess”	13
Mesenchymal stromal cells from umbilical cord Wharton's jelly trigger oligodendroglial differentiation in neural progenitor cells through cell-to-cell contact	13
Release kinetic of pro- and anti-inflammatory biomolecules from platelet-rich plasma and functional study on osteoarthritis synovial fibroblasts	13
NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitors	13
Umbilical cord–derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical data	13
Manufacturing of human Wharton's jelly stem cells for clinical use: selection of serum is important	12
Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy	12
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal	12
DC-based cancer vaccines: lessons from clinical trials	12
Retropatellar fat pad–derived stem cells from older osteoarthritic patients have lesser differentiation capacity and expression of stemness genes	12
Differentiated human adipose-derived stromal cells exhibit the phenotypic and functional characteristics of mature Schwann cells through a modified approach	12
Insights into animal models for cell-based therapies in translational studies of lung diseases: Is the horse with naturally occurring asthma the right choice?	12
CFU-megakaryocytic progenitors expanded ex vivo from cord blood maintain their in vitro homing potential and express matrix metalloproteinases	12
Comparison of two methodologies for the enrichment of mononuclear cells from thawed cord blood products: The automated Sepax system versus the manual Ficoll method	11
Transforming growth factor-β1-overexpressing mesenchymal stromal cells induced local tolerance in rat renal ischemia/reperfusion injury	11
Systematic review of controlled clinical studies using umbilical cord blood for regenerative therapy: Identifying barriers to assessing efficacy	11
Isolation of embryonic stem cells from enhanced green fluorescent protein-transgenic mouse and their survival in the cochlea after allotransplantation	11
Suppression of EBV release from irradiated B lymphoblastoid cell-lines: superior activity of ganciclovir compared with acyclovir	11
CD19 chimeric antigen receptor–redirected T cells combined with epidermal growth factor receptor pathway substrate 8 peptide–derived dendritic cell vaccine in leukemia	11
Human papilloma virus–specific T cells can be generated from naïve T cells for use as an immunotherapeutic strategy for immunocompromised patients	11
Heterogeneity of in vitro–cultured CD34+ cells isolated from peripheral blood	11
Early administration of tocilizumab (Toci) for the prevention of grade 4 cytokine release syndrome (CRS) after CD19-directed CAR T-cell therapy (CTL019)	11
Progress and challenges in generating functional hematopoietic stem/progenitor cells from human pluripotent stem cells	10
CD4+ bias in T cells cloned from a CML patient with active graft versus leukemia effect	10
Autologous cell sources in therapeutic vasculogenesis: In vitro and in vivo comparison of endothelial colony–forming cells from peripheral blood and endothelial cells isolated from adipose tissue	10
Automated Good Manufacturing Practice–compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle i	10
Developing a co-culture system for effective megakaryo/thrombopoiesis from umbilical cord blood hematopoietic stem/progenitor cells	10
Intrathecal cell therapy with autologous stromal cells increases cerebral glucose metabolism and can offer a new approach to the treatment of Alzheimer's type dementia	10
Mesenchymal stromal cells from adipose tissue attached to suture material enhance the closure of enterocutaneous fistulas in a rat model	10
Autologous bone marrow–derived CD133 cells with core decompression as a novel treatment method for femoral head osteonecrosis: a pilot study	10
Removal process of prion and parvovirus from human platelet lysates used as clinical-grade supplement for ex vivo cell expansion	10
Perspectives of the International Society for Cell & Gene Therapy Gastrointestinal Scientific Committee on the Intravenous Use of Mesenchymal Stromal Cells in Inflammatory Bowel Disease (PeMeGi)	10
Optimization of methodology for production of CD25/CD71 allodepleted donor T cells for clinical use	10
T-cell receptor gene-modified cells: past promises, present methodologies and future challenges	10
Cell culture media notably influence properties of human mesenchymal stroma/stem-like cells from different tissues	9
New method for the isolation of endothelial cells from large vessels	9
Similar proteomic profiles of human mesenchymal stromal cells from different donors	9
The use of unlicensed bone marrow–derived platelet lysate–expanded mesenchymal stromal cells in colitis: a pre-clinical study	9
Streamlined production of genetically modified T cells with activation, transduction and expansion in closed-system G-Rex bioreactors	9
The simultaneous isolation of multiple high and low frequent T-cell populations from donor peripheral blood mononuclear cells using the major histocompatibility complex I-Streptamer isolation technolo	9
Expansion of megakaryocyte progenitors from cryopreserved leukocyte concentrates of human placental and umbilical cord blood in short-term liquid culture	9
Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experience	9
TEMPORARY REMOVAL: CD271 identifies functional human hepatic stellate cells, which localize in peri-sinusoidal and portal areas in liver after partial hepatectomy	9
Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damage	9
Low cytomegalovirus-specific T-cell counts at reactivation are associated with progression to high-level viremia or disease in seropositive recipients of hematopoietic cell grafts from seropositive bu	9
Application of a clinical grade CD34-mediated method for the enrichment of microvascular endothelial cells from fat tissue	9
Microporous acellular extracellular matrix combined with adipose-derived stem cell sheets as a promising tissue patch promoting articular cartilage regeneration and interface integration	9
Evaluation of different routes of administration and biodistribution of human amnion epithelial cells in mice	9
Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controls	8
Characteristic differences among osteogenic cell populations of rat bone marrow stromal cells isolated from untreated, hemolyzed or Ficoll-treated marrow	8
Comparison of trophic factors secreted from human adipose-derived stromal vascular fraction with those from adipose-derived stromal/stem cells in the same individuals	8
Bioactive factors secreted from mesenchymal stromal cells protect the intestines from experimental colitis in a three-dimensional culture	8
Primitive AML progenitors from most CD34+ patients lack CD33 expression but progenitors from many CD34− AML patients express CD33	8
Human CD141+ dendritic cells generated from adult peripheral blood monocytes	8
Natural killer cells differentiated in vitro from cord blood CD34 + cells are more advantageous for use as an immunotherapy than peripheral blood and cord blood natural killer cells	8
A Monte Carlo framework for managing biological variability in manufacture of autologous cell therapy from mesenchymal stromal cells therapies	8
Generation of mesenchymal stromal cells from HOXB4-expressing human embryonic stem cells	8
Polyunsaturated fatty acids confer cryoresistance on megakaryocytes generated from cord blood and also enhance megakaryocyte production from cryopreserved cord blood cells	8
T-cell therapies for T-cell lymphoma	8
Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington disease	8
Bone marrow mesenchymal stromal cell uptake extracellular vesicles from carbon tetrachloride-injured hepatocytes without differentiating into hepatocyte-like cells in a short period	8
Enrichment of vascular endothelial growth factor secreting mesenchymal stromal cells enhances therapeutic angiogenesis in a mouse model of hind limb ischemia	8
Isolation of a novel embryonic stem cell cord blood–derived population with in vitro hematopoietic capacity in the presence of Wharton's jelly–derived mesenchymal stromal cells	8
Cell and gene therapy manufacturing capabilities in Australia and New Zealand	8
Generation of Zika virus–specific T cells from seropositive and virus-naïve donors for potential use as an autologous or “off-the-shelf” immunotherapeutic	8
A stromal-free, serum-free system to expand ex vivo hematopoietic stem cells from mobilized peripheral blood of patients with hematologic malignancies and healthy donors	7
Ultrastructural and molecular analyzes of insulin-producing cells induced from human hepatoma cells	7
Matched sibling donor-derived piggybac CAR19 T cells induce remission of relapsed/refractory CD19+ malignancy following haematopoietic stem cell transplant	7

Critical testing and parameters for consideration when manufacturing and evaluating tumor–associated antigen-specific T cells	7
Cryopreservation and thawing of hematopoietic stem cell CD34-induced apoptosis through caspase pathway activation: Key role of granulocytes	7
Cardiomyogenic differentiation potential of human endothelial progenitor cells isolated from patients with myocardial infarction	7
The effects of culture conditions on the functionality of efficiently obtained mesenchymal stromal cells from human cord blood	7
Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients	7
Improved expansion of T cells in culture when isolated with an equipment-free, high-throughput, flow-through microfluidic module versus traditional density gradient centrifugation	7
Validation of a semi automatic device to standardize quantification of Colony-Forming Unit (CFU) on hematopoietic stem cell products	7
Bone marrow stem cells assuage radiation-induced damage in a murine model of distraction osteogenesis: A histomorphometric evaluation	7
Conditioned media from mesenchymal stromal cells and periodontal ligament fibroblasts under cyclic stretch stimulation promote bone healing in mouse calvarial defects	7
False positive endotoxin results in a DC product caused by (1→3)-β–d-glucans acquired from a sterilizing cellulose filter	7
In vitro generation of dendritic cells derived from cryopreserved CD34+ cells mobilized into peripheral blood in lymphoma patients	7
Biomarkers of bone healing induced by a regenerative approach based on expanded bone marrow–derived mesenchymal stromal cells	7
Safety issues of peribulbar injection of umbilical cord mesenchymal stem cell (UC-MSC) in patients with retinitis pigmentosa	7